ExploreWatchlistsPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Gross profit

HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Feb 28, 202696,121+5.40%
Feb 28, 202591,196+15.48%
Feb 29, 202478,970+8.63%
Feb 28, 202372,699+3.76%
Feb 28, 202270,067+1.29%
Feb 28, 202169,173-21.04%
Feb 29, 202087,603-1.21%
Feb 28, 201988,680-3.80%
Feb 28, 201892,182-0.63%
Feb 28, 201792,770-10.39%
Feb 29, 2016103,532+3.86%
Feb 28, 201599,680

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat